Minoryx Therapeutics and Neuraxpharm's experimental therapy for genetic neurodegenerative disorder cerebral adrenoleukodystrophy (cALD) has shown that it can slow down the progression of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results